teclistamab,talquetamab,daratumumab
genmab,janssen
['redirectt-1', 'congrat']
congratulations on the wonderful presentation of the redirectt-1 study results at #eha2023. #mycompany 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options for pts with cancer. Tweets/views shared are my own